Leukemia - Chronic Myeloid - CML: Statistics; ... About 10% of all leukemia is CML. Survival rates of chronic myeloid leukemia are based on outcomes of people who've had the disease. Causes. While this type of leukemia is much more common in adults, it can affect children, too. Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia. : Chronic Myelogenous Leukemia Prognosis and Evolution 99 5. General classification. Normally, bone marrow cells mature into several different types of blood cells. Original Article. Leukemia is a cancer of early blood-forming cells, most frequently of the white blood cells although some leukemias begin on other blood cell types. CML is also called chronic myeloid leukemia. General Leukemia Questions. Evolution of the Disease Chronic myelogenous leukemia is characterized by a biphasic course, initially a chronic phase and then a blast crisis, passing from the initial stage to the final one by an intermediate stage, the accelerated phase. Information about chronic myelomonocytic leukemia (CMML), including what you should know and what you should do if you have CMML. Learn more about its treatment options and prognosis. This blast phase is refractory to treatment and results in imminent death. The median survival for patients is 3-5 months (7) and conventional therapies such as hydroxyurea and interferon do not alter the course of CML is caused by a chromosomal problem. Percent of New Cases by Age Group: Leukemia Leukemia is most frequently diagnosed among people aged 65-74. Chronic myelogenous leukemia (CML) is a Chronic myelogenous leukemia (also called CML or chronic granulocytic leukemia) is a slowly progressing blood and bone marrow disease that usually occurs during or after middle age, and rarely occurs in children. The first division is between its acute and chronic forms: It is treated with chemotherapy. Chronic myelogenous leukemia (CML) is an uncommon type of cancer of the blood cells. Find the survival rates for chronic myeloid leukemia here. The number of new cases of leukemia was 13.7 per 100,000 men and women per year based on 2010-2014 cases. Back to FAQ Categories. Chronic myelogenous leukemia is a disease in which the bone marrow makes too many white blood cells. Back to FAQ Categories. Chronic myeloid leukaemia (CML) is a form of blood cancer, which affects the white blood cells known as myeloid cells. Those with chronic myeloid leukemia should be ... Understanding chronic myeloid leukemia. Survival rates of chronic myeloid leukemia are based on outcomes of people who've had the disease. Clinically and pathologically, leukemia is subdivided into a variety of large groups. Survival rates of childhood leukemia are based on outcomes of people who've had the disease. Chronic myeloid leukaemia (CML) is a form of blood cancer, which affects the white blood cells known as myeloid cells. ... CML or Chronic Myelogenous Leukemia is a slow growing form of leukemia affecting the myeloid cells in Chronic myeloid leukemia, or CML, may strike at any age but tends to affect adults over age 50. Chronic myeloid leukaemia (CML) is a type of cancer that affects the blood and bone marrow. The five-year survival rate is 40%, except for APL (Acute Promyelocytic Leukemia), which has a survival rate greater than 90%. Thanks to advances in therapy and clinical trials, the outlook for kids with CML is promising. General Leukemia Questions. Chronic myeloid leukemia, or CML, may strike at any age but tends to affect adults over age 50. Acute myelogenous leukemia (AML) occurs more commonly in adults than in children, and more commonly in men than women. Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia. Learn about chronic myelogenous leukemia (CML) symptoms such as night sweats, hot flashes, fever without infection, chills, fatigue and joint pain.